Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FADTG
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,799
Award facts
- Contract value 100% obligated
- $21,798.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,798.86 to AmerSourceBergen Drug Corp for the supply of XELJANZ XR 11 mg tablets (30-tablet units). This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is scheduled for completion by January 12, 2026. The award was issued on January 9, 2026, with performance to be fulfilled at AmerSourceBergen's corporate office location in Conshohocken, Pennsylvania. XELJANZ XR is a prescription medication used in the treatment of rheumatoid arthritis and other inflammatory conditions, representing the company's continued role as a critical pharmaceutical supplier to federal healthcare systems.
This delivery order operates under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This comprehensive IDC serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The arrangement demonstrates AmerSourceBergen's established capability to efficiently fulfill federal procurement requirements for essential pharmaceuticals across multiple therapeutic domains serving military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FADTG?
SPE2DR26FADTG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FADTG worth?
The government has obligated $21,799 on SPE2DR26FADTG.
Is contract SPE2DR26FADTG an order under another contract?
Yes. SPE2DR26FADTG is a delivery order under SPE2DR25D2011, an indefinite delivery contract.
Was contract SPE2DR26FADTG competed?
The extent of competition for SPE2DR26FADTG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award